T

Teyi Pharmaceutical Group Co Ltd
SZSE:002728

Watchlist Manager
Teyi Pharmaceutical Group Co Ltd
SZSE:002728
Watchlist
Price: 8.73 CNY -3.43% Market Closed
Market Cap: 4.5B CNY
Have any thoughts about
Teyi Pharmaceutical Group Co Ltd?
Write Note

Net Margin
Teyi Pharmaceutical Group Co Ltd

12.3%
Current
19%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
12.3%
=
Net Income
103.7m
/
Revenue
842.6m

Net Margin Across Competitors

Country CN
Market Cap 4.5B CNY
Net Margin
12%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 710.5B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.3T DKK
Net Margin
35%
Country US
Market Cap 373.5B USD
Net Margin
17%
Country US
Market Cap 251.1B USD
Net Margin
19%
Country CH
Market Cap 202.7B CHF
Net Margin
20%
Country CH
Market Cap 183.3B CHF
Net Margin
35%
Country UK
Market Cap 162.4B GBP
Net Margin
13%
Country IE
Market Cap 146B USD
Net Margin
-126%
No Stocks Found

Teyi Pharmaceutical Group Co Ltd
Glance View

Market Cap
4.5B CNY
Industry
Pharmaceuticals

Teyi Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and pharmaceutical health industry. The company is headquartered in Jiangmen, Guangdong and currently employs 1,200 full-time employees. The company went IPO on 2014-07-31. The firm primarily provides Chinese traditional patent medicines, including cough arresting and phlegm removing medicine series, kidney reinforcing medicine series and anti-infection medicine series, among others. The firm's products mainly include tablets, granules, medicinal tea, syrup, decocted extracts, capsules, powder, ointment, cream, as well as oral solutions, among others.

Intrinsic Value
12.84 CNY
Undervaluation 32%
Intrinsic Value
Price
T

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
12.3%
=
Net Income
103.7m
/
Revenue
842.6m
What is the Net Margin of Teyi Pharmaceutical Group Co Ltd?

Based on Teyi Pharmaceutical Group Co Ltd's most recent financial statements, the company has Net Margin of 12.3%.